FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

697995005: ipilimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2968411014 Ipilimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2968417013 Ipilimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
729031000241112 ipilimumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
818541000172116 ipilimumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ipilimumab Has disposition (attribute) Cytotoxic T-lymphocyte-associated protein 4 inhibitor true Inferred relationship Some
Ipilimumab est un(e) (attribut) Cytotoxic T-lymphocyte-associated protein 4 inhibitor true Inferred relationship Some
Ipilimumab est un(e) (attribut) Immunosuppressant (substance) true Inferred relationship Some
Ipilimumab est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
Ipilimumab est un(e) (attribut) Antineoplastic agent (substance) true Inferred relationship Some
Ipilimumab est un(e) (attribut) anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Ipilimumab Has disposition (attribute) Murine-human monoclonal immunoglobulin G antibody (disposition) false Inferred relationship Some
Ipilimumab Has disposition (attribute) Immunomodulator (disposition) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Ipilimumab only product a pour principe actif (attribut) True Ipilimumab Inferred relationship Some 1
Product containing only ipilimumab in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Ipilimumab Inferred relationship Some 1
Ipilimumab 5 mg/mL solution for infusion Has precise active ingredient True Ipilimumab Inferred relationship Some 1
Ipilimumab 5 mg/mL solution for infusion Has basis of strength substance (attribute) True Ipilimumab Inferred relationship Some 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ipilimumab Inferred relationship Some 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Ipilimumab Inferred relationship Some 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Ipilimumab Inferred relationship Some 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance (attribute) True Ipilimumab Inferred relationship Some 1
Ipilimumab 5mg/mL solution for intravenous infusion a pour principe actif (attribut) False Ipilimumab Inferred relationship Some
Product containing ipilimumab (medicinal product) a pour principe actif (attribut) True Ipilimumab Inferred relationship Some 1
Ipilimumab-containing product in parenteral dose form a pour principe actif (attribut) True Ipilimumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start